Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Oct;64(10):5173-6.
doi: 10.1128/JVI.64.10.5173-5176.1990.

A sigma 1 region important for hemagglutination by serotype 3 reovirus strains

Affiliations

A sigma 1 region important for hemagglutination by serotype 3 reovirus strains

T S Dermody et al. J Virol. 1990 Oct.

Abstract

Hemagglutination (HA) by the mammalian reoviruses is mediated by interactions between the viral sigma 1 protein and sialoglycoproteins on the erythrocyte surface. Three serotype 3 (T3) reovirus strains were identified that do not agglutinate either bovine or type O human erythrocytes (HA negative): T3 clone 43 (T3C43), T3 clone 44 (T3C44), and T3 clone 84 (T3C84). These three strains also showed a diminished capacity to bind the major erythrocyte sialoglycoprotein, glycophorin, in an enzyme-linked immunosorbent assay. To determine the molecular basis for these findings, we examined the deduced sigma 1 amino acid sequences of the three HA-negative T3 strains and four HA-positive T3 strains. The limited number of sequence differences in the sigma 1 proteins of these seven strains allowed us to identify single unique amino acid residues in each of the HA-negative strains (aspartate 198 in T3C43, leucine 204 in T3C44, and tryptophan 202 in T3C84) that cluster within a discrete region of the sigma 1 tail. The identification of sigma 1 residues important for HA and glycophorin binding suggests that tail-forming sequences are exposed on the virion surface, where they interact with carbohydrate residues on the surface of cells.

PubMed Disclaimer

References

    1. Virology. 1988 Dec;167(2):601-12 - PubMed
    1. J Virol. 1988 Dec;62(12):4594-604 - PubMed
    1. Virology. 1989 Sep;172(1):382-5 - PubMed
    1. J Virol. 1990 Jun;64(6):2976-89 - PubMed
    1. J Virol. 1990 Jun;64(6):2990-3000 - PubMed

Publication types

LinkOut - more resources